Anti-B3GALT2 antibodies are used in the immunodetection of the protein beta-1,3-galactosyltransferase 2. In humans, the canonical protein has a reported length of 422 amino acid residues and a mass of 49.2 kDa. Its subcellular localization is in the Golgi. It is notably expressed in the heart and brain. A member of the Glycosyltransferase 31 protein family, B3GALT2 is a reported Beta-1,3-galactosyltransferase that transfers galactose from UDP-galactose to substrates with a terminal beta-N-acetylglucosamine (beta-GlcNAc) residue. Synonyms for this target antigen include GLCT2, beta3Gal-T2, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2, beta-1,3-GalTase 2, and BETA3GALT2. B3GALT2 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. ELISA is the most common application for the B3GALT2 antibodies listed below. Western Blot and Immunohistochemistry are also common applications.